CLONZOLIQ Trademark

Trademark Overview

On Thursday, April 3, 2025, a trademark application was filed for CLONZOLIQ with the United States Patent and Trademark Office. The USPTO has given the CLONZOLIQ trademark a serial number of 99118965. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, May 26, 2026. This trademark is owned by CMP Development LLC. The CLONZOLIQ trademark is filed in the Pharmaceutical Products category with the following description:

Cardiovascular pharmaceutical preparations

General Information

Serial Number99118965
Word MarkCLONZOLIQ
Filing DateThursday, April 3, 2025
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, May 26, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 2, 2025

Trademark Statements

Goods and ServicesCardiovascular pharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCMP Development LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFarmville, NC 27828
US
Party NameCMP Development LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFarmville, NC 27828
US

Trademark Events

Event DateEvent Description
Thursday, April 3, 2025NEW APPLICATION ENTERED
Thursday, April 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 3, 2025APPLICATION FILING RECEIPT MAILED
Friday, July 25, 2025TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, July 25, 2025TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, September 1, 2025ASSIGNED TO EXAMINER
Monday, September 8, 2025NON-FINAL ACTION WRITTEN
Monday, September 8, 2025NON-FINAL ACTION E-MAILED
Monday, September 8, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 3, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 3, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 3, 2025TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, October 3, 2025PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, October 31, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 2, 2025PUBLISHED FOR OPPOSITION
Tuesday, December 2, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 27, 2026NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 26, 2026SOU TEAS EXTENSION RECEIVED
Tuesday, May 26, 2026SOU EXTENSION 1 FILED
Tuesday, May 26, 2026SOU EXTENSION 1 GRANTED
Wednesday, May 27, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

clonzoliq preparations pharmaceutical cardiovascular